Infusion 51a and BioWise Capital make a splash in the 75th NYC PostGraduate Assembly in Anesthesiology
Chicago, IL. Dec 13, 2021. Infusion 51a and BioWise Capital brought their expertise together in partnership at the 75th PostGraduate Assembly in Anesthesiology (PGA), celebrated this weekend in New York City, to offer physicians the opportunity to co-invest as LPs into disruptive life sciences and biotechnology. The PGA is sponsored by the New York State […]
Vivacitas Oncology Announces Additions to Leadership Team and Board
Vivacitas Oncology, Inc. is pleased to announce the addition of Mark Suseck as new Director and Chief Executive Officer and Frank D. Heuszel as Director.
Vivacitas Oncology, Inc. and Image Analysis Group to Present on AR-67 Clinical Response Evaluation at the Society for Neuro-oncology Annual Conference
Walnut Creek, CA, USA, and London, UK, November 18, 2021, Vivacitas Oncology, a privately-held oncology company focused on tough–to–treat cancers, and Image Analysis Group (IAG), a premier image analysis company and developer of the proprietary Artificial Intelligence (AI)-assisted Dynamika™ platform will present a poster at this year’s annual Society of Neuro-Oncology (SNO) conference November 18-21, […]
Infusion 51a co-founded company Vivacitas Oncology closes $1 million from DSS as it explores going public
DSS Continues to Grow its Healthcare Segment through $1M Investment in Vivacitas Oncology ROCHESTER, N.Y., August 2, 2021 (GLOBE NEWSWIRE) — Document Security Systems, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating business segments in blockchain security, direct marketing, healthcare, consumer packaging, real estate, renewable energy, and securitized digital assets, announced […]